Health & Environmental Research Online (HERO)


Print Feedback Export to File
8312800 
Journal Article 
A Randomized, Multi-Center, Open-Label Study to Evaluate the Efficacy of Carvedilol vs. Propranolol to Reduce Portal Pressure in Patients With Liver Cirrhosis 
Kim, SG; Kim, TY; Sohn, JH; Um, SH; Seo, YS; Baik, SK; Kim, MY; Jang, JY; Jeong, SW; Lee, B; Kim, YS; Suk, KT; Kim, DJ; , 
2016 
Yes 
American Journal of Gastroenterology
ISSN: 0002-9270
EISSN: 1572-0241 
NATURE PUBLISHING GROUP 
NEW YORK 
1582-1590 
English 
27575713 
WOS:000394047300022 
Propranolol has been used as prophylaxis for variceal bleeding in patients with cirrhosis. More recent data suggest that carvedilol may be more effective for reducing the hepatic venous pressure gradient (HVPG) than propranolol. The primary aim of this study was to evaluate the hemodynamic response to carvedilol compared with propranolol.